Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2007
07/12/2007WO2006123256A3 Hivcon: an hiv immunogen and uses thereof
07/12/2007WO2006116458B1 Modified oligoribonucleotide analogs with enhances immunostimulatory activity
07/12/2007WO2006109197A3 Reducing levels of nicotinic alkaloids in plants
07/12/2007WO2006105343A3 Dkkl-i splice product modulators for cancer diagnosis and therapy
07/12/2007WO2006091094A3 Hemoglobin overexpression in fungal fermentations
07/12/2007WO2006065552A3 Modulating plant nitrogen levels
07/12/2007WO2006031999A3 Modulating plant sugar levels
07/12/2007WO2005122750A3 Novel maize split-seed explant and methods for in vitro regeneration of maize
07/12/2007WO2005027962A3 4’-thionucleosides and oligomeric compounds
07/12/2007WO2005019409A3 Combinatorial protein library screening by periplasmic expression
07/12/2007WO2005012487A3 Compositions and methods for preparing short rna molecules and other nucleic acids
07/12/2007WO2004039990A3 Cells for determining the presence of a molecule that activates signal transduction activity of a cell surface protein
07/12/2007US20070163009 Polynucleotides encoding phytase polypeptides
07/12/2007US20070163007 Agrobacterium-mediated gene introduction into a plant material comprising treating the plant material and then infecting the plant material with an Agrobacterium, characterized in that a medium enriched in a metal salt containing copper ion is used
07/12/2007US20070163006 determining susceptibility of a potato to after-cooking darkening comprising assaying a potato sample for a nucleic acid molecule encoding a cinnamic acid 4-hydroxylase protein from potato; darkening due to oxidation of an iron-chlorogenic acid complex
07/12/2007US20070163005 Pm29 and lea3 promoters and use in expression of transgenic genes in plants
07/12/2007US20070163004 Plants with reduced activity of a starch phosphorylating enzyme
07/12/2007US20070163003 Plants with increased activity of multiple starch phosphorylating enzymes
07/12/2007US20070163002 Fatty acid desaturases and mutant sequences thereof
07/12/2007US20070163001 Generation of plants with altered oil content
07/12/2007US20070163000 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP.
07/12/2007US20070162999 Crop Plant Cystatin Proteinase Inhibitors and Methods of Use
07/12/2007US20070162998 CeCPI: taro cysteine protease inhibitor
07/12/2007US20070162997 Genetic markers linked to fusarium head blight-resistance factor and utilization thereof
07/12/2007US20070162996 Inbred Corn Line PH8JV
07/12/2007US20070162995 Nitrogen-efficient monocot plants
07/12/2007US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
07/12/2007US20070162993 Geranylgeranyl pyrophosphate synthases
07/12/2007US20070162991 Transgenic mice containing Lrp5 gene disruptions
07/12/2007US20070162987 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
07/12/2007US20070162986 Anf analogue
07/12/2007US20070161712 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
07/12/2007US20070161596 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
07/12/2007US20070161594 Compositions and their uses directed to il-4r alpha
07/12/2007US20070161593 Compositions and their uses directed to il-4r alpha
07/12/2007US20070161591 Methods and compositions for treating neurological disease
07/12/2007US20070161590 Methods and sequences to preferentially suppress expression of mutated huntingtin
07/12/2007US20070161589 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents
07/12/2007US20070161586 Drug for preventing and treating atherosclerosis
07/12/2007US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same
07/12/2007US20070161584 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein
07/12/2007US20070161565 Signal transduction protein TAB2
07/12/2007US20070161564 Methods for making Apo-2 ligand using divalent metal ions
07/12/2007US20070161562 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
07/12/2007US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
07/12/2007US20070161558 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
07/12/2007US20070161556 Antifungal Therapeutic targets
07/12/2007US20070161554 Treatment of neurodegenerative diseases by the use of laptm4b
07/12/2007US20070161549 Glycosylation-deficient hepatocyte growth factor
07/12/2007US20070161547 Modulation of survivin expression
07/12/2007US20070161531 Subtilase variants
07/12/2007US20070161110 Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter
07/12/2007US20070161099 Methods for using polypeptides having amylase activity and nucleic acids encoding them
07/12/2007US20070161098 Method for producing lactic acid
07/12/2007US20070161091 Corynebacterium glutamicum genes encoding proteins involved in genetic stability, gene expression, and protein secretion and folding
07/12/2007US20070161090 Method for producing purine nucleoside by fermentation
07/12/2007US20070161087 Glp-1 fusion proteins
07/12/2007US20070161086 Novel ecdysone receptor-based induicible gene expression system
07/12/2007US20070161083 Codon Optimized Recombinant Dermaphagoides Allergens
07/12/2007US20070161082 Lipase variants
07/12/2007US20070161080 Antibodies
07/12/2007US20070161065 DIAGNOSIS, PREVENTION AND TREATMENT OF CROHN'S DISEASE USING THE OmpC ANTIGEN
07/12/2007US20070161061 Novel composition and methods for the treatment of immune related diseases
07/12/2007US20070161054 Methods and compositions for targeting secretory lysosomes
07/12/2007US20070161046 Truncated aggrecanase molecules
07/12/2007US20070161045 Fusion proteins based upon somatostatin receptors
07/12/2007US20070161043 Methods of Preparing Multicolor Quantum Dot Tagged Beads and Conjugates Thereof
07/12/2007US20070161040 Hybrid proteins of active-site serine beta-lactamase
07/12/2007US20070161036 Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations and for detecting single nucleotide polymorphisms (SNPs) or point mutations in genomic DNA
07/12/2007US20070161035 Plant Myb Transcription Factor Homologs
07/12/2007US20070161024 Method for Gene Identification Signature (GIS) Analysis
07/12/2007US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
07/12/2007US20070161014 Nucleic acid binding proteins
07/12/2007US20070161004 Methods and compositions involving microRNA
07/12/2007US20070161002 Growth differentiation factor promoter and uses therefor
07/12/2007US20070161000 Plasmid purification
07/12/2007US20070160999 Method for simultaneous extraction of nucleic acids from a biological sample
07/12/2007US20070160987 Human g protein-coupled receptor and modulators thereof for the treatment of inflammatory disorders
07/12/2007US20070160982 Development of influenza a antivirals
07/12/2007US20070160630 Hepatitis-c virus 4, 5 and 6
07/12/2007US20070160629 Purified active HCV NS2/3 protease
07/12/2007US20070160627 wherein IL1 beta R coding sequence has been inactivated for use in immunotherapy and vaccination, wherein MVA mutant comprises DNA sequences coding for a heterologous protein derived from therapeutic polypeptides and polypeptides of pathogenic agents, wherein MVA mutant leads to enhanced memory response
07/12/2007US20070160623 Innate immune system-directed vaccines
07/12/2007US20070160614 Human TIMP-1 antibodies
07/12/2007US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
07/12/2007US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/12/2007US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL)
07/12/2007US20070160595 Human Tumor Necrosis Factor TR20 and Methods Based Thereon
07/12/2007US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders
07/12/2007US20070160585 Remedy for prion disease and method of producing the same
07/12/2007US20070160581 Production of ssDNA in vivo
07/12/2007US20070160575 Anth1 chimeric antagonist
07/12/2007US20070160570 Chimeric polypeptides containing chemokine domains
07/12/2007US20070160545 Method for reducing ultraviolet light induced apoptosis
07/12/2007US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use
07/12/2007US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands
07/12/2007US20070160504 Separating small, negatively charged, polyelectrolyte coated particles such as water soluble dyes from mixture using microfluidic apparatus; high throughput assays; for removing small negatively charged molecules
07/12/2007DE102006000942A1 Adenylat-Zyklase, für die Adenylat-Zyklase kodierende Gensequenz, Vektoren und Zellen sowie deren Verwendung Adenylate cyclase-encoding adenylate cyclase gene sequence, vectors and cells and their use
07/12/2007CA2674210A1 Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment
07/12/2007CA2636184A1 Gene promoters that can be used in plants